Early detection of amyloid load using 18F-florbetaben PET

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1758-9193

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Early detection of amyloid load using 18F-florbetaben PET ; volume:13 ; number:1 ; day:27 ; month:3 ; year:2021 ; pages:1-15 ; date:12.2021
Alzheimer's research & therapy ; 13, Heft 1 (27.3.2021), 1-15, 12.2021

Creator: Bullich, Santiago
Roé-Vellvé, Núria
Marquié, Marta
Landau, Susan M.
Barthel, Henryk
Villemagne, Victor L.
Sanabria, Ángela
Tartari, Juan Pablo
Sotolongo-Grau, Oscar
Doré, Vincent
Koglin, Norman
Müller, Andre
Perrotin, Audrey
Jovalekic, Aleksandar
Santi, Susan De
Tárraga, Lluís
Stephens, Andrew W.
Rowe, Christopher C.
Sabri, Osama
Seibyl, John P.
Boada, Mercè

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13195-021-00807-6

URN: urn:nbn:de:101:1-2021051402425070796450

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:46 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Bullich, Santiago
Roé-Vellvé, Núria
Marquié, Marta
Landau, Susan M.
Barthel, Henryk
Villemagne, Victor L.
Sanabria, Ángela
Tartari, Juan Pablo
Sotolongo-Grau, Oscar
Doré, Vincent
Koglin, Norman
Müller, Andre
Perrotin, Audrey
Jovalekic, Aleksandar
Santi, Susan De
Tárraga, Lluís
Stephens, Andrew W.
Rowe, Christopher C.
Sabri, Osama
Seibyl, John P.
Boada, Mercè
SpringerLink (Online service)

Other Objects (12)

Quantification of Tau Load Using [18F]AV1451 PET

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment

18F-Florbetaben PET beta-amyloid binding expressed in Centiloids

Concordance in detecting amyloid positivity between 18F-florbetaben and 18F-flutemetamol amyloid PET using quantitative and qualitative assessments

Assessment of perfusion deficit with early phases of [18F]PI-2620 tau-PET versus [18F]flutemetamol-amyloid-PET recordings

Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET

18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition

18F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases

The diagnostic performance of 18F-FAMT PET and 18F-FDG PET for malignancy detection: a meta-analysis

Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition

Feasibility of in vivo 18F-florbetaben PET/MR imaging of human carotid amyloid-β

Quantification of Tau Load Using [18F]AV1451 PET

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment

18F-Florbetaben PET beta-amyloid binding expressed in Centiloids

Concordance in detecting amyloid positivity between 18F-florbetaben and 18F-flutemetamol amyloid PET using quantitative and qualitative assessments

Assessment of perfusion deficit with early phases of [18F]PI-2620 tau-PET versus [18F]flutemetamol-amyloid-PET recordings

Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET

18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition

18F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases

The diagnostic performance of 18F-FAMT PET and 18F-FDG PET for malignancy detection: a meta-analysis

Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition

Feasibility of in vivo 18F-florbetaben PET/MR imaging of human carotid amyloid-β

Quantification of Tau Load Using [18F]AV1451 PET

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment

18F-Florbetaben PET beta-amyloid binding expressed in Centiloids

Concordance in detecting amyloid positivity between 18F-florbetaben and 18F-flutemetamol amyloid PET using quantitative and qualitative assessments

Assessment of perfusion deficit with early phases of [18F]PI-2620 tau-PET versus [18F]flutemetamol-amyloid-PET recordings

Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET

18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition

18F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases

The diagnostic performance of 18F-FAMT PET and 18F-FDG PET for malignancy detection: a meta-analysis

Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition

Feasibility of in vivo 18F-florbetaben PET/MR imaging of human carotid amyloid-β

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Early detection of amyloid load using 18F-florbetaben PET

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Quantification of Tau Load Using [18F]AV1451 PET

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment

18F-Florbetaben PET beta-amyloid binding expressed in Centiloids

Concordance in detecting amyloid positivity between 18F-florbetaben and 18F-flutemetamol amyloid PET using quantitative and qualitative assessments

Assessment of perfusion deficit with early phases of [18F]PI-2620 tau-PET versus [18F]flutemetamol-amyloid-PET recordings

Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET

18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition

18F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases

The diagnostic performance of 18F-FAMT PET and 18F-FDG PET for malignancy detection: a meta-analysis

Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition

Feasibility of in vivo 18F-florbetaben PET/MR imaging of human carotid amyloid-β

Feasibility of in vivo 18F-florbetaben PET/MR imaging of human carotid amyloid-β

Quantification of Tau Load Using [18F]AV1451 PET

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment

18F-Florbetaben PET beta-amyloid binding expressed in Centiloids

Concordance in detecting amyloid positivity between 18F-florbetaben and 18F-flutemetamol amyloid PET using quantitative and qualitative assessments

Assessment of perfusion deficit with early phases of [18F]PI-2620 tau-PET versus [18F]flutemetamol-amyloid-PET recordings

Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET

18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition

18F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases

The diagnostic performance of 18F-FAMT PET and 18F-FDG PET for malignancy detection: a meta-analysis

Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition

Feasibility of in vivo 18F-florbetaben PET/MR imaging of human carotid amyloid-β

Feasibility of in vivo 18F-florbetaben PET/MR imaging of human carotid amyloid-β

Quantification of Tau Load Using [18F]AV1451 PET

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment

18F-Florbetaben PET beta-amyloid binding expressed in Centiloids

Concordance in detecting amyloid positivity between 18F-florbetaben and 18F-flutemetamol amyloid PET using quantitative and qualitative assessments

Assessment of perfusion deficit with early phases of [18F]PI-2620 tau-PET versus [18F]flutemetamol-amyloid-PET recordings

Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET

18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition

18F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases

The diagnostic performance of 18F-FAMT PET and 18F-FDG PET for malignancy detection: a meta-analysis

Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition

Feasibility of in vivo 18F-florbetaben PET/MR imaging of human carotid amyloid-β

Feasibility of in vivo 18F-florbetaben PET/MR imaging of human carotid amyloid-β

Related objects

Reset password